Key Insights

Highlights

Success Rate

67% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 72/100

Termination Rate

12.5%

2 terminated out of 16 trials

Success Rate

66.7%

-19.8% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

25%

1 of 4 completed with results

Key Signals

1 with results67% success

Data Visualizations

Phase Distribution

8Total
Not Applicable (3)
P 1 (1)
P 2 (4)

Trial Status

Completed4
Unknown4
Recruiting4
Terminated2
Not Yet Recruiting1
Withdrawn1

Trial Success Rate

66.7%

Benchmark: 86.5%

Based on 4 completed trials

Clinical Trials (16)

Showing 16 of 16 trials
NCT06853223Phase 2RecruitingPrimary

This Study is Assessing the Safety and Efficacy of Immune Inhibition as a Treatment to Prevent Primary Graft Dysfunction

NCT07230886Not ApplicableNot Yet RecruitingPrimary

Prospective Reduction Of Transplant Complications Through Enhanced Preservation Therapy to Prevent Primary Graft Dysfunction

NCT00457847RecruitingPrimary

Identifying Genetic Characteristics That Increase Risk of Primary Graft Dysfunction Following Lung Transplantation

NCT00552357RecruitingPrimary

Risk Factors That Increase the Chance of Developing Primary Graft Dysfunction After Lung Transplantation

NCT05691205Not ApplicableCompleted

Identifying Optimal PEEP After Lung Transplantation

NCT04558333Terminated

CLAD: Finding Biomarkers to Predict Rejection and/ or Outcome After Lung Transplantation

NCT06159933Not ApplicableCompleted

Primary Graft Dysfunction, Pronation, Bilateral Lung Transplants

NCT04505878Phase 2WithdrawnPrimary

Perioperative Vitamin C Lung Transplant

NCT05375149Recruiting

Exhaled Breath Particles in Lung Transplantation

NCT01715883Phase 2TerminatedPrimary

Sodium Nitrite in Lung Transplant Patients to Minimize the Risk of Pulmonary Graft Dysfunction

NCT01605214UnknownPrimary

Measurement of Extravascular Lung Water to Detect and Predict Primary Graft Dysfunction Following Lung Transplant

NCT03156894UnknownPrimary

Heart Transplant and Primary Transplant Dysfunction: a Retrospective Analysis of the Strasbourg Experience

NCT02032069CompletedPrimary

Pneumoproteins Expression in the Organ Donor

NCT01967953Phase 1Completed

Ex-Vivo Lung Perfusion to Increase the Number of Organs for Transplantation

NCT01151826UnknownPrimary

Quantifying Physical and Biochemical Factors That Contribute to Primary Graft Dysfunction After Lung Transplantation

NCT00506532Phase 2Unknown

The Use of Surfactant in Lung Transplantation: A Randomized Control Pilot Study

Showing all 16 trials

Research Network

Activity Timeline